company background image
EBAC

European Biotech Acquisition NasdaqCM:EBAC Stock Report

Last Price

US$10.15

Market Cap

US$166.4m

7D

0.3%

1Y

4.1%

Updated

01 Feb, 2023

Data

Company Financials

European Biotech Acquisition Corp.

NasdaqCM:EBAC Stock Report

Mkt Cap: US$166.4m

EBAC Stock Overview

European Biotech Acquisition Corp. does not have significant operations.

EBAC fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance1/6
Financial Health3/6
Dividends0/6

My Notes

New

Notes are coming soon

European Biotech Acquisition Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for European Biotech Acquisition
Historical stock prices
Current Share PriceUS$10.15
52 Week HighUS$10.65
52 Week LowUS$9.66
Beta0
1 Month Change0.50%
3 Month Change1.60%
1 Year Change4.10%
3 Year Changen/a
5 Year Changen/a
Change since IPOn/a

Recent News & Updates

Recent updates

Shareholder Returns

EBACUS Capital MarketsUS Market
7D0.3%0.5%0.2%
1Y4.1%-13.5%-13.6%

Return vs Industry: EBAC exceeded the US Capital Markets industry which returned -13.5% over the past year.

Return vs Market: EBAC exceeded the US Market which returned -13.6% over the past year.

Price Volatility

Is EBAC's price volatile compared to industry and market?
EBAC volatility
EBAC Average Weekly Movement0.3%
Capital Markets Industry Average Movement0.6%
Market Average Movement6.9%
10% most volatile stocks in US Market17.3%
10% least volatile stocks in US Market2.8%

Stable Share Price: EBAC is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 0% a week.

Volatility Over Time: EBAC's weekly volatility (0%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2021n/aEduardo Bravo de Araozhttps://www.lspvc.com/ebac

European Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on business in the life sciences industry in Europe.

European Biotech Acquisition Corp. Fundamentals Summary

How do European Biotech Acquisition's earnings and revenue compare to its market cap?
EBAC fundamental statistics
Market CapUS$166.45m
Earnings (TTM)US$860.48k
Revenue (TTM)n/a

193.4x

P/E Ratio

0.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
EBAC income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other Expenses-US$860.48k
EarningsUS$860.48k

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.052
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did EBAC perform over the long term?

See historical performance and comparison